Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205741 | SCV000261226 | benign | Multiple endocrine neoplasia, type 2 | 2023-01-26 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727042 | SCV000705107 | uncertain significance | not provided | 2017-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000597255 | SCV000723971 | likely benign | not specified | 2018-02-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Counsyl | RCV000663014 | SCV000786030 | likely benign | Multiple endocrine neoplasia type 2A | 2018-02-06 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256118 | SCV002529970 | likely benign | Hereditary cancer-predisposing syndrome | 2020-09-21 | criteria provided, single submitter | curation | |
Ce |
RCV000727042 | SCV002821503 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | RET: BS1 |